Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL1787323

NC(=O)c1ccc(O)c(Cl)c1.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.46
PARP1 P09874 2/20 0.42
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
LCK P06239 1/20 0.41
CA2 P00918 4/20 0.40
HSD17B10 Q99714 2/20 0.39
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
CA1 P00915 2/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
BCAT2 O15382 1/20 0.38
RORC P51449 2/20 0.38
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30765123 0.85 LCK (0.53) PARP1HSP90AA1HSP90AB1LCKCA2
SCHEMBL1786932 0.85 LCK (0.53) PARP1HSP90AA1HSP90AB1LCKCA2
SCHEMBL2789841 0.76 HSD11B1 (0.56) HSD11B1PARP1CA2CA1BCAT2
SCHEMBL1786127 0.73 HSD11B1 (0.44) HSD11B1PARP1BCAT2
Trifluoroacetic Acid SCHEMBL13269478 0.72 KLK1 (0.50) HSP90AA1HSP90AB1CA2HSD17B1HSD17B2
SCHEMBL4294249 0.71 HSD11B1 (0.45) HSD11B1PARP1BCAT2MAOB
SCHEMBL1383113 0.71 CA2 (0.56) HSD11B1CA2CA1CA12CA9
SCHEMBL7323561 0.71 F10 (0.44) HSP90AA1HSP90AB1CA2HSD17B10CA1
Trifluoroacetic Acid SCHEMBL4403326 0.70 TSHR (0.55) HSD11B1PARP1BCAT2TSHR
Hydrochloric Acid SCHEMBL30536936 0.70 HSD11B1 (0.44) HSD11B1PARP1BCAT2MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633175-B2 Compounds as antagonists or inverse agonists at opioid receptors GLAXOSMITHKLINE LLC (US) 2014-01-21 US disclosed
US-20110124559-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2011-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110124559-A1 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS OPRL1, OPRM1, OPRK1 HSD11B1 1876/4885PARP1 4618/4885HSP90AA1 3353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.